Technical Platform
  • Core competence
  • Cell line development
  • Development platform
  • Commercialization activities
  • Quality analytical
  • Equipment and facilities
Your location : Home > Technical > Core competence

       Development of biologic drugs including the now popular biosimilars, poses significant technical challenges. Knowledge and expertise in many different areas are required, including lead compound development and evaluation, process design and development and large-scale manufacturing. ANNPO Bio excels throughout the full spectrum, from molecular biology to mass production of biologics, giving us a distinct competitive advantage.

      The folks in charge at ANNPO Bio have years of hands-on experience in commercialization of biologics. They possess an in depth understanding of the enormous challenges that are inherent in drug development. For a protein drug to have a successful clinical trial and then get to market, stable production and effective quality monitoring are essential. Our experience, knowledge and application of effective risk management strategies allow us to expedite drug development and production, leading to early benefits for patients and continued success in the long term. 

      Getting our product on the market so that patients can benefit is the primary goal of drug development and indeed of ANNPO Bio. Our team is well equipped to lead the way in achieving this goal.